Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Derivation of a score to predict infection due to multidrug-resistant Pseudomonas aeruginosa: a tool for guiding empirical antibiotic treatment.
Hernández-Jiménez P, López-Medrano F, Fernández-Ruiz M, Silva JT, Corbella L, San-Juan R, Ruiz-Ruigómez M, Lizasoain M, Rodríguez-Goncer I, Díaz-Regañón J, López-Mendoza D, Viedma E, Aguado JM. Hernández-Jiménez P, et al. Among authors: diaz reganon j. J Glob Antimicrob Resist. 2022 Jun;29:215-221. doi: 10.1016/j.jgar.2022.03.014. Epub 2022 Mar 24. J Glob Antimicrob Resist. 2022. PMID: 35339736 Free article.
Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017).
Cantón R, Loza E, Aznar J, Castillo FJ, Cercenado E, Fraile-Ribot PA, González-Romo F, López-Hontangas JL, Rodríguez-Lozano J, Suárez-Barrenechea AI, Tubau F, Díaz-Regañón J, López-Mendoza D; SMART-Spain Working Group. Cantón R, et al. Rev Esp Quimioter. 2019 Apr;32(2):145-155. Epub 2019 Feb 13. Rev Esp Quimioter. 2019. PMID: 30761824 Free PMC article.
Activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacterales isolates recovered from intensive care unit patients in Spain: The SUPERIOR multicentre study.
García-Fernández S, García-Castillo M, Bou G, Calvo J, Cercenado E, Delgado M, Pitart C, Mulet X, Tormo N, Mendoza DL, Díaz-Regañón J, Cantón R; SUPERIOR Study Group. García-Fernández S, et al. Int J Antimicrob Agents. 2019 May;53(5):682-688. doi: 10.1016/j.ijantimicag.2019.02.004. Epub 2019 Feb 12. Int J Antimicrob Agents. 2019. PMID: 30769199
Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS.
Hernández-García M, García-Castillo M, García-Fernández S, Melo-Cristino J, Pinto MF, Gonçalves E, Alves V, Vieira AR, Ramalheira E, Sancho L, Diogo J, Ferreira R, Silva T, Chaves C, Bou G, Cercenado E, Delgado-Valverde M, Oliver A, Pitart C, Rodríguez-Lozano J, Tormo N, Romano J, Pássaro L, Paixão L, López-Mendoza D, Díaz-Regañón J, Cantón R; STEP and SUPERIOR study groups. Hernández-García M, et al. J Antimicrob Chemother. 2021 Jan 19;76(2):370-379. doi: 10.1093/jac/dkaa430. J Antimicrob Chemother. 2021. PMID: 33099623
Antimicrobial activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa recovered during the Study for Monitoring Antimicrobial Resistance Trends (SMART) program in Spain (2016-2018).
Cantón R, Loza E, Arcay RM, Cercenado E, Castillo FJ, Cisterna R, Gálvez-Benítez L, González Romo F, Hernández-Cabezas A, Rodríguez-Lozano J, Suárez-Barrenechea AI, Tubau F, Díaz-Regañón J, López-Mendoza D; SMART-Spain Working Group. Cantón R, et al. Rev Esp Quimioter. 2021 Jun;34(3):228-237. doi: 10.37201/req/019.2021. Epub 2021 Mar 1. Rev Esp Quimioter. 2021. PMID: 33645948 Free PMC article.
Presence of Chromosomal crpP-like Genes Is Not Always Associated with Ciprofloxacin Resistance in Pseudomonas aeruginosa Clinical Isolates Recovered in ICU Patients from Portugal and Spain.
Hernández-García M, García-Castillo M, García-Fernández S, López-Mendoza D, Díaz-Regañón J, Romano J, Pássaro L, Paixão L, Cantón R. Hernández-García M, et al. Microorganisms. 2021 Feb 14;9(2):388. doi: 10.3390/microorganisms9020388. Microorganisms. 2021. PMID: 33672870 Free PMC article.
WGS characterization of MDR Enterobacterales with different ceftolozane/tazobactam susceptibility profiles during the SUPERIOR surveillance study in Spain.
Hernández-García M, García-Fernández S, García-Castillo M, Bou G, Cercenado E, Delgado-Valverde M, Mulet X, Pitart C, Rodríguez-Lozano J, Tormo N, López-Mendoza D, Díaz-Regañón J, Cantón R; SUPERIOR study group. Hernández-García M, et al. Among authors: diaz reganon j. JAC Antimicrob Resist. 2020 Oct 22;2(4):dlaa084. doi: 10.1093/jacamr/dlaa084. eCollection 2020 Dec. JAC Antimicrob Resist. 2020. PMID: 34223039 Free PMC article.
A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?
Gómez-Zorrilla S, Becerra-Aparicio F, López Montesinos I, Ruiz de Gopegui E, Grau I, Pintado V, Padilla B, Benito N, Boix-Palop L, Fariñas MC, Peñaranda M, Gamallo MR, Martinez JA, Morte-Romea E, Del Pozo JL, Durán-Jordá X, Díaz-Regañón J, López-Mendoza D, Cantón R, Oliver A, Ruiz-Garbajosa P, Horcajada JP; REIPI/GEIRAS-GEMARA SEIMC ITUBRAS-2 Group. Gómez-Zorrilla S, et al. Among authors: diaz reganon j. Infect Dis Ther. 2021 Dec;10(4):2677-2699. doi: 10.1007/s40121-021-00537-0. Epub 2021 Oct 9. Infect Dis Ther. 2021. PMID: 34626347 Free PMC article.
Risk Factors and Outcomes for Multidrug Resistant Pseudomonas aeruginosa Infection in Immunocompromised Patients.
Hernández-Jiménez P, López-Medrano F, Fernández-Ruiz M, Silva JT, Corbella L, San-Juan R, Lizasoain M, Díaz-Regañón J, Viedma E, Aguado JM. Hernández-Jiménez P, et al. Among authors: diaz reganon j. Antibiotics (Basel). 2022 Oct 23;11(11):1459. doi: 10.3390/antibiotics11111459. Antibiotics (Basel). 2022. PMID: 36358114 Free PMC article.
28 results